Background Image
Table of Contents Table of Contents
Previous Page  24 / 66 Next Page
Information
Show Menu
Previous Page 24 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 3, May/June 2021

134

AFRICA

and geometric characteristics and cardiovascular risk in South

African populations.

The non-invasive assessment of vascular healthwithFMDand

retinal imaging are deemed useful as a marker of cardiovascular

risk and disease, yet there is a paucity of studies utilising these

technologies in the South African research context. The growing

interest in vascular and endothelial measurements as future

diagnostic and screening tools in the clinical setting necessitates

that baseline values are established for a variety of populations,

including those living in low- to middle-income countries such

as South Africa. In South Africa, current evidence suggests that

the Western Cape Province has a particularly high prevalence of

cardiovascular risk factors.

In view of the above, the present proof-of-concept study was

undertaken to record baseline FMD and retinal microvascular

and geometric data in a cohort of apparently healthy

participants from Cape Town. The study additionally aimed to

determine whether a relationship exists between FMD, retinal

parameters and traditional cardiovascular risk factors in the

study participants.

Methods

For this cross-sectional study, 66 HIV-free and otherwise

apparently healthy participants were recruited from the Uitsig

community health clinic near Cape Town between September

2014 and July 2015, as a pilot to a larger parent study.

22

Participants were eligible for inclusion if they were adults (18

years or older), willing to give written consent for participation

in the study and undergo HIV testing. Screening for HIV

infection was performed with a rapid HIV test (SD Bioline HIV

1/2 3.0 immunochromatographic test kit; Standard Diagnostics,

Republic of Korea). Participants were excluded if they were

pregnant or tested positive for HIV infection.

The study received ethics approval from the Health Research

Ethics Committee (HREC) of Stellenbosch University (HREC

reference number: N13/05/064) and was conducted according

to the ethical guidelines and principles of the international

Declaration of Helsinki, South African Guidelines for Good

Clinical Practice and the Medical Research Council of South

Africa Ethical Guidelines for Research. All participants supplied

written, informed consent for participation in the study, and

additionally provided written consent for HIV testing for which

appropriate pre- and post-test counselling was provided by a

qualified research nurse.

Information regarding participants’ medical history, including

smoking status, was gathered via a structured interview and

health questionnaire. Additionally, participants were weighed

and anthropometric measurements recorded to determine

body mass index (BMI), waist circumference and waist-to-hip

ratio (WHR) according to international guidelines.

23

A return

visit was scheduled where participants were required to fast

from 22h00 the previous night, and to refrain from smoking,

drinking coffee or doing exercise for four to six hours prior

to the assessments in order to comply with standard subject

preparation recommendations for FMD measurements.

24

Blood samples were collected and immediately transported

to the closest laboratory of the National Health Laboratory

Services [a South African National Standard (SANS) accredited

laboratory service provider] where the following fasting

biochemical measurements were performed: total cholesterol,

high-density lipoprotein cholesterol (HDL-C), low-density

lipoprotein cholesterol (LDL-C), triglycerides, glucose and

glycated haemoglobin (HbA

1c

). Appropriate assays were used

for quantifying the concentrations of the above markers with a

Roche/Hitachi cobas c 311, cobas c 501/502 analyser.

Subsequently, before endothelial function assessments were

performed, systolic and diastolic blood pressures were measured

in the left arm at three different occasions, two to five minutes

apart, with an Omron M6 automatic digital blood pressure

monitor (Omron Healthcare, Kyoto, Japan).

The FMD protocol is designed to expose the brachial artery

to post-occlusion hyperaemia and the subsequent shear stress-

induced release of NO and other pro-vasodilatory factors,

resulting in vasodilation that can be imaged and quantified as an

index of vasomotor function.

25

In this study, FMD assessment

was performed using a MyLab™ Five mobile ultrasound system

(Esaote, Italy). The FMD protocol was similar to previously

published recommendations.

25,26

Participants were asked to lie supine on an examination bed,

with their right arm abducted and supinated. A blood pressure

cuff (deflated) was placed around the proximal part of the

forearm. Subsequently, the ultrasound probe was positioned

proximal to the cubital fossa (mid to distal humerus), just below

the biceps brachii

muscle belly, until the brachial artery was

located visually on the ultrasound image. The ultrasound probe

was secured in this position using a probe holder. Next, cross-

sectional still images were captured with the ultrasound probe

at three different locations along the designated section of the

artery to obtain baseline brachial artery diameter measurements.

Following this, the blood pressure cuff was inflated to 200

mmHg (or 50 mmHg supra-systolic in the case of individuals

with a systolic blood pressure greater than 150 mmHg) and

blood flow to the forearm was occluded for five minutes. After

the blood pressure cuff was deflated, additional cross-sectional

ultrasound stills were taken along the same section of artery for

a duration of two minutes.

For still analysis, the MyLab™ Five mobile ultrasound system

built-in manual measurement tool was used to measure the

brachial artery diameter in millimetres, consistently at the end of

diastole, in all the stills. The three baseline measurements were

used to calculate a mean baseline brachial artery diameter, and the

maximum post-occlusion measurement, usually at approximately

60 seconds after blood pressure cuff release, was used to calculate

the FMD percentage according the following formula:

FMD % = ​ 

maximum post-occlusion (diameter (mm) – mean baseline diameter (mm)

____________________________________________

mean baseline diameter (mm)

​× 100

In order to ensure reliable data collection, the ultrasound

operators were subjected to stringent training by experts and

multiple practice sessions on student volunteers and colleagues.

To keep inter-operator variability to the minimum, only three

trained and experienced operators were employed in this study,

and only one person independently performed the image analysis

and data acquisition.

Retinal images were captured using a Canon CR-2

non-mydriatic digital retinal camera (Canon Europa NV, the

Netherlands) based on protocols previously published.

27

Optic

disc-centred fundus images of both eyes were obtained. For the

static retinal microvascular assessments, images were analysed

using MONA REVA™ software version 2.0.2 (Vito, Belgium).